Metoprolol Terapia (Metoprolol Tartrate)

Metoprolol Tartrate selectively blocks β1‑adrenergic receptors in the heart. By preventing adrenaline and noradrenaline from binding, it lowers heart rate, reduces the strength of each heartbeat, and diminishes cardiac output, which together help lower blood pressure and lessen oxygen demand by the heart muscle.

The dose of Metoprolol Terapia is individualized by the prescribing clinician based on the patient’s condition, response, and any co‑existing medical issues. The prescriber determines the appropriate strength, frequency, and titration schedule to achieve therapeutic goals while monitoring safety.

Safety data for Metoprolol Tartrate in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers should discuss individual circumstances and consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol is a cardio‑selective (β1‑specific) blocker, offering a lower risk of bronchospasm compared with non‑selective agents such as propranolol. It is commonly chosen for patients with respiratory disease or those needing precise heart‑rate control, while still providing effective blood‑pressure reduction.

Metoprolol Terapia should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Metoprolol Terapia is taken orally, usually as a tablet. It is swallowed whole with a glass of water, and can be taken with or without food unless the prescriber advises otherwise. Patients should follow the dosing schedule provided by their healthcare professional.

Serious adverse events include severe bradycardia, marked hypotension, heart block, worsening heart‑failure symptoms, and bronchospasm in susceptible individuals. Any sudden dizziness, fainting, shortness of breath, or chest discomfort should prompt immediate medical evaluation.

Metoprolol Terapia is contraindicated in patients with known hypersensitivity to metoprolol or any component of the formulation, in those with severe bradycardia, second‑ or third‑degree atrioventricular block without a pacemaker, and in individuals with uncompensated heart failure or severe asthma/COPD.